Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Financial Officer

Chief Legal Officer

Chief Operating Officer

Chief Executive Officer

Chief Business Officer

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selec...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-15	Premium	sold	Premium	Premium	Premium	-
2024-03-14	Premium	sold	Premium	Premium	Premium	-
2024-03-13	Premium	sold	Premium	Premium	Premium	-
2024-03-13	Premium	sold	Premium	Premium	Premium	-
2024-03-13	Premium	sold	Premium	Premium	Premium	-
2024-03-12	Premium	sold	Premium	Premium	Premium	-
2024-03-12	Premium	sold	Premium	Premium	Premium	-
2024-03-12	Premium	sold	Premium	Premium	Premium	-
2024-03-11	Premium	sold	Premium	Premium	Premium	-
2024-03-11	Premium	sold	Premium	Premium	Premium	-
2024-03-11	Premium	sold	Premium	Premium	Premium	-
2024-03-04	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-04	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	-
2024-02-21	Premium	acquired	Premium	Premium	Premium	-
2024-02-20	Premium	sold	Premium	Premium	Premium	-
2024-02-20	Premium	acquired	Premium	Premium	Premium	-
2024-02-09	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

KYMR - Kymera Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for KYMR